Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | DNM1 | Q05193 | 7/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL117309 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL11695805 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL2341027 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL50789 | 1.00 | — | — | |
| SCHEMBL4195383 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Hexane SCHEMBL25218797 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL2175777 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL5974474 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL10320275 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL134259 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9409843-B2 | Method for producing 1,1,1,5,5,5-hexafluoroacetylacetone | CENTRAL GLASS COMPANY, LIMITED (JP) | 2016-08-09 | — | — | US | disclosed |
| US-20160075626-A1 | Method for Producing 1,1,1,5,5,5-Hexafluoroacetylacetone | CENTRAL GLASS COMPANY LIMITED (JP) | 2016-03-17 | — | — | US | disclosed |
| EP-2512979-A2 | HYDROGEN STORAGE AND/OR GENERATION | California Institute of Technology (US) | 2012-10-24 | — | — | EP | disclosed |
| US-20110171119-A1 | HYDROGEN STORAGE AND/OR GENERATION | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2011-07-14 | — | — | US | disclosed |
| WO-2011081949-A2 | HYDROGEN STORAGE AND/OR GENERATION | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2011-07-07 | — | — | WO | disclosed |
| US-7034081-B2 | Highly branched diene polymers | BAYER AKTIENGESELLSCHAFT (DE) | 2006-04-25 | — | — | US | disclosed |
| US-6841648-B2 | Polymers modified by functional groups | BAYER AKTIENGESELLSCHAFT (DE) | 2005-01-11 | — | — | US | disclosed |
| US-20040054110-A1 | Highly branched diene polymers | LANXESS DEUTSCHLAND GMBH (DE) | 2004-03-18 | — | — | US | disclosed |
| EP-1398329-A1 | Highly branched diene polymers | Bayer Aktiengesellschaft (DE) | 2004-03-17 | — | — | EP | disclosed |
| US-20030125476-A1 | Polymers modified by functional groups | BAYER AKTIENGESELLSCHAFT (DE) | 2003-07-03 | — | — | US | disclosed |
| US-20030114612-A1 | Coupled diene polymers modified with electrophilic groups | BAYER AKTIENGESELLSCHAFT (DE) | 2003-06-19 | — | — | US | disclosed |
| EP-1319673-A1 | Polymers, modified by functionalised groups | BAYER AG (DE) | 2003-06-18 | — | — | EP | disclosed |
| EP-1283220-A1 | Coupled diene polymers modified with electrophilic groups | Bayer Aktiengesellschaft (DE) | 2003-02-12 | — | — | EP | disclosed |
| US-6136921-A | ALKALI METAL-TERMINATED POLYMER REACTED WITH DIGLYCIDYL ETHER DERIVATIVE COUPLING AGENT; CORROSION AND WEAR RESISTANCE; RADIATION TRANSPARENT | TAIWAN SYNTHETIC RUBBER CORPERATION (TW) | 2000-10-24 | — | — | US | disclosed |
| US-4229367-A | Preparation of trans-4-alkyl-cyanoarylcyclohexanes | SIEGFRIED AKTIENGESELLSCHAFT (CH) | 1980-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160075626-A1 | Method for Producing 1,1,1,5,5,5-Hexafluoroacetylacetone | TALDO1, HDHD5, AQP1 | TSHR 2062/4885THRB 3283/4885DNM1 507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.